Literature DB >> 6977507

Biological effects of Cf-252 neutrons at low dose rates.

J M Feola, C A Nava, Y Maruyama.   

Abstract

The EMT6 tumour of the Balb/c mouse and the LSA ascites lymphoma of the C57BL/YM mouse have been used to study the effects of Cf-252 neutrons at low dose rates. EMT6 and LSA cells were irradiated in vitro in a hypoxic state; EMT6/KY cells were plated after exposure for colony-forming ability assays, while TD50 assays were used to test the tumour-forming ability of LSA cells. EMT6 cells showed r.b.e.n values of 5.3, 4.7, and 3.0 for Cf-252 dose rates of 26.8, 10.2, and 5.2 cGy/hour (= rad/hour), respectively, when compared to Cs-137 irradiations at dose rates of 79.7, 25.7 and 12.1 cGy/hour, respectively. The LSA ascites gave r.b.e.n values of 5.6 and 5.2 at dose rates of 27.0 and 6.94 cGy/hour of Cf-252, when compared to Cs-137 irradiations at 79.6 and 24.9 cGy/hour, respectively. However, changes in r.b.e. values for both systems were entirely dependent on comparison with Cs-137 survival curves.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977507     DOI: 10.1080/09553008214550031

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  3 in total

1.  CT and MR for brain tumor implant therapy using CF-252 neutrons.

Authors:  Y Maruyama; H W Chin; A B Young; J Beach; P Tibbs; S Goldstein; W Markesbery
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

2.  RBE of spleen CFU-S to low dose rate Cf-252 neutron or photon radiation.

Authors:  Y Maruyama; J M Feola; H N Hwang; A Williams; J L Beach
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

3.  Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.

Authors:  Shen Qian; Ling Ye; Yun-Hong Tian; Li-Gen Wang; Zuo-Ping Huang; Feng Li; Bing Hou; Ni Song; Juan Chen; Ying Liu; Xiao Liu; Tao Zhou
Journal:  Chin J Cancer       Date:  2017-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.